Carpal Tunnel Syndrome, Pain, Postoperative
Conditions
Brief summary
Carpal Tunnel Syndrome patients undergoing carpal tunnel release surgery performed by the PI will receive intra-operative injections of bupivacaine (Marcaine). Two groups of patients will be randomly selected and will receive either 10cc or 20cc of injection. Their post-operative pain scores and usage of post-operative pain medication will be recorded and analyzed.
Detailed description
This randomized control trial will be conducted at the USF Department of Orthopaedics at the USF Health Morsani Center after receiving approval from the USF Institutional Review Board. Patients will be evaluated Carpal Tunnel Syndrome and screened as candidates for Carpal Tunnel Release surgery, following the inclusion and exclusion criteria. The Medical Record Number (MRN) will be used to randomly assign into treatment interventions. Group 1 and group 2 will receive 10cc and 20cc of intra-operative intra-carpal tunnel anesthetic injection, respectively. Postoperatively, patients will be prescribed an opioid pain medication in congruence with current standard medical practice. Patients will be contacted at 24-hours, 48-hours, 72-hours, and at 2-week clinic follow-up by research staff and will be evaluated for pain levels through the LIKERT scale and pain management through use of prescribed and supplemental pain medications. All data will be analyzed through SPSS v25.
Interventions
DRUG10cc injection of bupivacaine
10cc intra-operative injection of bupivacaine into the carpal tunnel of the operative hand/wrist
DRUG20cc injection of bupivacaine
20cc intra-operative injection of bupivacaine into the carpal tunnel of the operative hand/wrist
Sponsors
University of South Florida
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* patient must be undergoing carpal tunnel release surgery performed by PI * EMG or Ultrasound diagnosed carpal tunnel syndrome
Exclusion criteria
* co-musculoskeletal injuries
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Pain Level in various stages of the post-operative period | Changes in pain scores at 24 hours, 48 hours, 72 hours, and 2 weeks post-operatively | The investigator will implement a survey using a LIKERT scale regarding post-operative pain levels. |
Countries
United States
Outcome results
None listed